Loading...
Doximity, Inc.
DOCS•NYSE
Healthcare
Medical - Healthcare Information Services
$61.00
$1.62(2.73%)
Doximity, Inc. (DOCS) Financial Performance & Statements
Review Doximity, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.45%
↑ 13.45%
Operating Income Growth
30.99%
↑ 30.99%
Net Income Growth
30.81%
↑ 30.81%
Operating Cash Flow Growth
2.50%
↑ 2.50%
Operating Margin
39.94%
↑ 39.94%
Gross Margin
90.20%
↑ 90.20%
Net Profit Margin
39.13%
↑ 39.13%
ROE
22.38%
↑ 22.38%
ROIC
20.56%
↑ 20.56%
Doximity, Inc. (DOCS) Financial Statements
Explore quarterly and annual reports for Doximity, Inc. stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $168.60M | $136.83M | $126.68M | $118.06M |
| Cost of Revenue | $14.18M | $13.68M | $13.55M | $12.57M |
| Gross Profit | $154.42M | $123.16M | $113.13M | $105.49M |
| Gross Profit Ratio | $0.92 | $0.90 | $0.89 | $0.89 |
| R&D Expenses | $22.42M | $23.24M | $22.57M | $20.15M |
| SG&A Expenses | $52.08M | $44.47M | $44.30M | $43.49M |
| Operating Expenses | $74.50M | $70.01M | $66.87M | $63.64M |
| Total Costs & Expenses | $88.68M | $83.69M | $80.42M | $76.20M |
| Interest Income | $9.89M | $9.11M | $7.17M | $6.03M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $2.61M | $2.56M | $2.55M |
| EBITDA | $79.92M | $58.06M | $48.82M | $44.40M |
| EBITDA Ratio | $0.47 | $0.42 | $0.39 | $0.38 |
| Operating Income | $79.92M | $53.14M | $46.26M | $41.85M |
| Operating Income Ratio | $0.47 | $0.39 | $0.37 | $0.35 |
| Other Income/Expenses (Net) | $9.91M | $9.03M | $7.12M | $6.10M |
| Income Before Tax | $89.84M | $62.17M | $53.17M | $47.95M |
| Income Before Tax Ratio | $0.53 | $0.45 | $0.42 | $0.41 |
| Income Tax Expense | $14.64M | $18.02M | $11.79M | $7.33M |
| Net Income | $75.20M | $44.15M | $41.38M | $40.62M |
| Net Income Ratio | $0.45 | $0.32 | $0.33 | $0.34 |
| EPS | $0.40 | $0.24 | $0.22 | $0.22 |
| Diluted EPS | $0.37 | $0.22 | $0.21 | $0.20 |
| Weighted Avg Shares Outstanding | $187.16M | $186.25M | $185.61M | $186.76M |
| Weighted Avg Shares Outstanding (Diluted) | $202.23M | $200.41M | $199.22M | $201.11M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan